|
Ezensimva 10/10
Simvastatin + ezetimibe
- Strength / route
- 10mg + 10mg · Oral
- Qty
- 20,000 Tablet
- Total
- 60,000,000
- Group
- N4
- Manufacturer
- Agimexpharm Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thanh Hoa · 38180
|
893110015400 |
10mg + 10mg
Oral
|
Tablet |
20,000
|
3,000
|
60,000,000
|
N4 |
Agimexpharm Pharmaceutical JSC
Vietnam
|
Thanh Hoa
38180
|
2026-03-06 |
|
Faskit
zinc gluconat
- Strength / route
- 70mg/1g · Oral
- Qty
- 14,000 Sachet
- Total
- 12,530,000
- Group
- N4
- Manufacturer
- Ha Tay Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Binh · 44001
|
893110102024 |
70mg/1g
Oral
|
Sachet |
14,000
|
895
|
12,530,000
|
N4 |
Ha Tay Pharmaceutical JSC
Vietnam
|
Quang Binh
44001
|
2026-03-06 |
|
Faslodex
Fulvestrant
- Strength / route
- 50mg/ml · Injection
- Qty
- 48 Syringe
- Total
- 301,879,200
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vetter Pharma - Fertigung GmbH & Co.KG; Secondary packaging site: AstraZeneca UK Limited (Country of manufacture and primary packaging: Germany; Country of secondary packaging: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-19561-16 |
50mg/ml
Injection
|
Syringe |
48
|
6,289,150
|
301,879,200
|
N1 |
Manufacturing and primary packaging site: Vetter Pharma - Fertigung GmbH & Co.KG; Secondary packaging site: AstraZeneca UK Limited
Country of manufacture and primary packaging: Germany; Country of secondary packaging: United Kingdom
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Faszeen
Cefradin
- Strength / route
- 250mg · Oral
- Qty
- 4,000 Sachet
- Total
- 20,600,000
- Group
- N4
- Manufacturer
- Ha Tay Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Binh · 44001
|
893110096823 |
250mg
Oral
|
Sachet |
4,000
|
5,150
|
20,600,000
|
N4 |
Ha Tay Pharmaceutical JSC
Vietnam
|
Quang Binh
44001
|
2026-03-06 |
|
Fefasdin 180
Fexofenadin
- Strength / route
- 180mg · Oral
- Qty
- 8,730 Tablet
- Total
- 4,609,440
- Group
- N4
- Manufacturer
- Khanh Hoa Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ho Chi Minh City · 79831
|
893100483824 |
180mg
Oral
|
Tablet |
8,730
|
528
|
4,609,440
|
N4 |
Khanh Hoa Pharmaceutical JSC
Vietnam
|
Ho Chi Minh City
79831
|
2026-03-06 |
|
Femara
Letrozol
- Strength / route
- 2,5mg · Oral
- Qty
- 2,400 Tablet
- Total
- 163,934,400
- Group
- N1
- Manufacturer
- Manufacturing site: Novartis Pharma Stein AG; Packaging and batch release site: Novartis Farma S.p.A. (Manufacturing site: Switzerland; Packaging and batch release site: Italy)
- Province / Facility
- Ho Chi Minh City · 79037
|
760114186923 |
2,5mg
Oral
|
Tablet |
2,400
|
68,306
|
163,934,400
|
N1 |
Manufacturing site: Novartis Pharma Stein AG; Packaging and batch release site: Novartis Farma S.p.A.
Manufacturing site: Switzerland; Packaging and batch release site: Italy
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Fenbrat 200M
Fenofibrat micronised
- Strength / route
- 200mg · Oral
- Qty
- 50,000 Tablet
- Total
- 145,000,000
- Group
- N3
- Manufacturer
- Pharmaceutical and Medical Biology JSC – Branch (Vietnam)
- Province / Facility
- Bac Ninh · 27009
|
893110398724 |
200mg
Oral
|
Tablet |
50,000
|
2,900
|
145,000,000
|
N3 |
Pharmaceutical and Medical Biology JSC – Branch
Vietnam
|
Bac Ninh
27009
|
2026-03-06 |
|
Fenofib 100
Fenofibrat
- Strength / route
- 100mg · Oral
- Qty
- 12,000 Tablet
- Total
- 30,000,000
- Group
- N2
- Manufacturer
- OPV Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Binh · 44001
|
893110890324 |
100mg
Oral
|
Tablet |
12,000
|
2,500
|
30,000,000
|
N2 |
OPV Pharmaceutical JSC
Vietnam
|
Quang Binh
44001
|
2026-03-06 |
|
Fenofibrat 300 mg
Fenofibrat
- Strength / route
- 300mg · Oral
- Qty
- 30,000 Tablet
- Total
- 99,000,000
- Group
- N2
- Manufacturer
- SaVi Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thanh Hoa · 38180
|
VD-23652-15 |
300mg
Oral
|
Tablet |
30,000
|
3,300
|
99,000,000
|
N2 |
SaVi Pharmaceutical JSC
Vietnam
|
Thanh Hoa
38180
|
2026-03-06 |
|
Ferovin
iron protein succinylat
- Strength / route
- 40mg/15ml · Oral
- Qty
- 4,000 Sachet
- Total
- 29,080,000
- Group
- N4
- Manufacturer
- Vinh Phuc Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thanh Hoa · 38180
|
893110281824 |
40mg/15ml
Oral
|
Sachet |
4,000
|
7,270
|
29,080,000
|
N4 |
Vinh Phuc Pharmaceutical JSC
Vietnam
|
Thanh Hoa
38180
|
2026-03-06 |
|
Flixotide Evohaler
Fluticason propionat
- Strength / route
- 125mcg/ dose xit · Throat spray
- Qty
- 1,200 Spray canister
- Total
- 127,754,400
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-16267-13 |
125mcg/ dose xit
Throat spray
|
Spray canister |
1,200
|
106,462
|
127,754,400
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Flixotide Evohaler
Fluticason propionat
- Strength / route
- 125mcg/ dose xit (x120 dose) · Inhalation
- Qty
- 440 Spray canister
- Total
- 46,843,280
- Group
- N1
- Manufacturer
- Glaxo Wellcome S.A. (Spain)
- Province / Facility
- Ho Chi Minh City · 79021
|
VN-16267-13 |
125mcg/ dose xit (x120 dose)
Inhalation
|
Spray canister |
440
|
106,462
|
46,843,280
|
N1 |
Glaxo Wellcome S.A.
Spain
|
Ho Chi Minh City
79021
|
2026-03-06 |
|
Flumetholon 0,1
Fluorometholon
- Strength / route
- 5mg/5ml · Ophthalmic
- Qty
- 1,800 Vial
- Total
- 57,909,600
- Group
- N1
- Manufacturer
- Manufacturing site: Santen Pharmaceutical Co., Ltd. - Shiga Plant (Japan)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-18452-14 |
5mg/5ml
Ophthalmic
|
Vial |
1,800
|
32,172
|
57,909,600
|
N1 |
Manufacturing site: Santen Pharmaceutical Co., Ltd. - Shiga Plant
Japan
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
ForminHasan XR 500
Metformin hydroclorid
- Strength / route
- 500mg · Oral
- Qty
- 360,000 Tablet
- Total
- 204,120,000
- Group
- N4
- Manufacturer
- Hasan-Dermapharm Joint Venture Co., Ltd. (Vietnam)
- Province / Facility
- Bac Ninh · 27009
|
893110296924 |
500mg
Oral
|
Tablet |
360,000
|
567
|
204,120,000
|
N4 |
Hasan-Dermapharm Joint Venture Co., Ltd.
Vietnam
|
Bac Ninh
27009
|
2026-03-06 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 120,000 Tablet
- Total
- 2,280,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN3-37-18 |
10mg
Oral
|
Tablet |
120,000
|
19,000
|
2,280,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 100,000 Tablet
- Total
- 1,900,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (United States)
- Province / Facility
- Ho Chi Minh City · 79021
|
VN3-37-18 |
10mg
Oral
|
Tablet |
100,000
|
19,000
|
1,900,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
United States
|
Ho Chi Minh City
79021
|
2026-03-06 |
|
Forxiga
Dapagliflozin
- Strength / route
- 10mg · Oral
- Qty
- 100,000 Tablet
- Total
- 1,900,000,000
- Group
- N1
- Manufacturer
- Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd (Manufacturing site: United States, Packaging and batch release site: United Kingdom)
- Province / Facility
- Hanoi · 01918
|
VN3-37-18 |
10mg
Oral
|
Tablet |
100,000
|
19,000
|
1,900,000,000
|
N1 |
Manufacturing site: AstraZeneca Pharmaceuticals LP; Packaging and batch release site: AstraZeneca UK Ltd
Manufacturing site: United States, Packaging and batch release site: United Kingdom
|
Hanoi
01918
|
2026-03-06 |
|
Fosmicin tablets 500
Fosfomycin (natri)
- Strength / route
- 500mg · Oral
- Qty
- 6,000 Tablet
- Total
- 131,400,000
- Group
- N1
- Manufacturer
- Meiji Seika Pharmatech Co., Ltd. (Other name: Meiji Seika Pharma Co., Ltd - Odawara Plant) (Japan)
- Province / Facility
- Hanoi · 01918
|
VN-15983-12 |
500mg
Oral
|
Tablet |
6,000
|
21,900
|
131,400,000
|
N1 |
Meiji Seika Pharmatech Co., Ltd. (Other name: Meiji Seika Pharma Co., Ltd - Odawara Plant)
Japan
|
Hanoi
01918
|
2026-03-06 |
|
Fremedol 650
Paracetamol (acetaminophen)
- Strength / route
- 650mg · Oral
- Qty
- 85,000 Tablet
- Total
- 27,540,000
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Binh · 44001
|
VD-36006-22 |
650mg
Oral
|
Tablet |
85,000
|
324
|
27,540,000
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Quang Binh
44001
|
2026-03-06 |
|
Fresofol 1% Mct/Lct
Propofol
- Strength / route
- 1% (10mg/ml) · Injection
- Qty
- 150 Ampoule
- Total
- 13,200,000
- Group
- N1
- Manufacturer
- Fresenius Kabi Austria GmbH (Austria)
- Province / Facility
- Ho Chi Minh City · 79831
|
VN-17438-13 |
1% (10mg/ml)
Injection
|
Ampoule |
150
|
88,000
|
13,200,000
|
N1 |
Fresenius Kabi Austria GmbH
Austria
|
Ho Chi Minh City
79831
|
2026-03-06 |
|
Fretinum
Domperidon
- Strength / route
- 10mg · Oral
- Qty
- 45,515 Tablet
- Total
- 10,331,905
- Group
- N2
- Manufacturer
- Fremed Pharmaceutical JSC (Vietnam)
- Province / Facility
- Ho Chi Minh City · 79831
|
893110026724 |
10mg
Oral
|
Tablet |
45,515
|
227
|
10,331,905
|
N2 |
Fremed Pharmaceutical JSC
Vietnam
|
Ho Chi Minh City
79831
|
2026-03-06 |
|
Fucicort
Fusidic acid + betamethason
- Strength / route
- 2% (w/w) + 0,1% (w/w) · Topical
- Qty
- 1,000 Tube
- Total
- 98,340,000
- Group
- N1
- Manufacturer
- LEO Laboratories Limited (Ireland)
- Province / Facility
- Hanoi · 01006
|
539110417123 |
2% (w/w) + 0,1% (w/w)
Topical
|
Tube |
1,000
|
98,340
|
98,340,000
|
N1 |
LEO Laboratories Limited
Ireland
|
Hanoi
01006
|
2026-03-06 |
|
Fucicort
Fusidic acid + betamethason
- Strength / route
- 2% (w/w) + 0,1% (w/w) · Topical
- Qty
- 120 Tube
- Total
- 11,800,800
- Group
- N1
- Manufacturer
- LEO Laboratories Limited (Ireland)
- Province / Facility
- Hanoi · 01043
|
539110417123 |
2% (w/w) + 0,1% (w/w)
Topical
|
Tube |
120
|
98,340
|
11,800,800
|
N1 |
LEO Laboratories Limited
Ireland
|
Hanoi
01043
|
2026-03-06 |
|
Fucidin
Fusidic acid
- Strength / route
- 2% (w/w) · Topical
- Qty
- 1,100 Tube
- Total
- 82,582,500
- Group
- N1
- Manufacturer
- Leo Laboratories Limited (Ireland)
- Province / Facility
- Ho Chi Minh City · 79021
|
VN-14209-11 |
2% (w/w)
Topical
|
Tube |
1,100
|
75,075
|
82,582,500
|
N1 |
Leo Laboratories Limited
Ireland
|
Ho Chi Minh City
79021
|
2026-03-06 |
|
Fucidin
Fusidic acid
- Strength / route
- 2% (w/w) · Topical
- Qty
- 100 Tube
- Total
- 7,507,500
- Group
- N1
- Manufacturer
- Leo Laboratories Limited (Ireland)
- Province / Facility
- Ho Chi Minh City · 79053
|
VN-14209-11 |
2% (w/w)
Topical
|
Tube |
100
|
75,075
|
7,507,500
|
N1 |
Leo Laboratories Limited
Ireland
|
Ho Chi Minh City
79053
|
2026-03-06 |
|
Fulphila 6mg/0.6ml
Pegfilgrastim
- Strength / route
- 6mg/0,6ml · Injection
- Qty
- 29 Syringe
- Total
- 231,884,000
- Group
- N2
- Manufacturer
- Biocon Biologics Limited (India)
- Province / Facility
- Hanoi · 01043
|
890410303824 |
6mg/0,6ml
Injection
|
Syringe |
29
|
7,996,000
|
231,884,000
|
N2 |
Biocon Biologics Limited
India
|
Hanoi
01043
|
2026-03-06 |
|
Galvus
Vildagliptin
- Strength / route
- 50mg · Oral
- Qty
- 90,000 Tablet
- Total
- 740,250,000
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-19290-15 |
50mg
Oral
|
Tablet |
90,000
|
8,225
|
740,250,000
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Galvus
Vildagliptin
- Strength / route
- 50mg · Oral
- Qty
- 60,000 Tablet
- Total
- 493,500,000
- Group
- N1
- Manufacturer
- Siegfried Barbera, S.L. (Spain)
- Province / Facility
- Ho Chi Minh City · 79021
|
840110412723 |
50mg
Oral
|
Tablet |
60,000
|
8,225
|
493,500,000
|
N1 |
Siegfried Barbera, S.L.
Spain
|
Ho Chi Minh City
79021
|
2026-03-06 |
|
Ganfort
Bimatoprost + timolol
- Strength / route
- 0,3mg/ml + 5mg/ml · Ophthalmic
- Qty
- 600 Vial
- Total
- 153,594,000
- Group
- N1
- Manufacturer
- Allergan Pharmaceuticals Ireland (Ireland)
- Province / Facility
- Ho Chi Minh City · 79037
|
539110019923 |
0,3mg/ml + 5mg/ml
Ophthalmic
|
Vial |
600
|
255,990
|
153,594,000
|
N1 |
Allergan Pharmaceuticals Ireland
Ireland
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Garnotal
Phenobarbital
- Strength / route
- 100 mg · Oral
- Qty
- 210,000 Tablet
- Total
- 66,150,000
- Group
- N2
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thanh Hoa · 38180
|
893112426324 |
100 mg
Oral
|
Tablet |
210,000
|
315
|
66,150,000
|
N2 |
Danapha Pharmaceutical JSC
Vietnam
|
Thanh Hoa
38180
|
2026-03-06 |
|
Garnotal
Phenobarbital
- Strength / route
- 100 mg · Oral
- Qty
- 3,000 Tablet
- Total
- 945,000
- Group
- N2
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01043
|
893112426324 |
100 mg
Oral
|
Tablet |
3,000
|
315
|
945,000
|
N2 |
Danapha Pharmaceutical JSC
Vietnam
|
Hanoi
01043
|
2026-03-06 |
|
Garnotal 10
Phenobarbital
- Strength / route
- 10 mg · Oral
- Qty
- 1,500 Tablet
- Total
- 315,000
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Hanoi · 01006
|
893112467324 |
10 mg
Oral
|
Tablet |
1,500
|
210
|
315,000
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Hanoi
01006
|
2026-03-06 |
|
Garnotal Inj
Phenobarbital
- Strength / route
- 200mg/2 ml · Injection
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Tri · 45053
|
VD-16785-12 |
200mg/2 ml
Injection
|
Ampoule |
0
|
12,600
|
0
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Quang Tri
45053
|
2026-03-06 |
|
Garnotal Inj
Phenobarbital
- Strength / route
- 200mg/2 ml · Injection
- Qty
- 40 Ampoule
- Total
- 504,000
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Tri · 45004
|
VD-16785-12 |
200mg/2 ml
Injection
|
Ampoule |
40
|
12,600
|
504,000
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Quang Tri
45004
|
2026-03-06 |
|
Garnotal Inj
Phenobarbital
- Strength / route
- 200mg/2 ml · Injection
- Qty
- 40 Ampoule
- Total
- 504,000
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Tri · 45407
|
VD-16785-12 |
200mg/2 ml
Injection
|
Ampoule |
40
|
12,600
|
504,000
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Quang Tri
45407
|
2026-03-06 |
|
Garnotal Inj
Phenobarbital
- Strength / route
- 200mg/2 ml · Injection
- Qty
- 0 Ampoule
- Total
- 0
- Group
- N4
- Manufacturer
- Danapha Pharmaceutical JSC (Vietnam)
- Province / Facility
- Quang Tri · 45060
|
VD-16785-12 |
200mg/2 ml
Injection
|
Ampoule |
0
|
12,600
|
0
|
N4 |
Danapha Pharmaceutical JSC
Vietnam
|
Quang Tri
45060
|
2026-03-06 |
|
Gastrosanter
magnesium hydroxyd + nhom hydroxyd
- Strength / route
- 400mg + 400mg;2,5g · Oral
- Qty
- 66,000 Sachet
- Total
- 171,600,000
- Group
- N4
- Manufacturer
- Ha Tay Pharmaceutical JSC (Vietnam)
- Province / Facility
- Thanh Hoa · 38180
|
893100205824 |
400mg + 400mg;2,5g
Oral
|
Sachet |
66,000
|
2,600
|
171,600,000
|
N4 |
Ha Tay Pharmaceutical JSC
Vietnam
|
Thanh Hoa
38180
|
2026-03-06 |
|
Gemzar
Gemcitabin
- Strength / route
- 200mg · Injection
- Qty
- 60 Vial
- Total
- 44,130,000
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vianex S.A.- Plant C (Secondary packaging and batch release site: Lilly France) (Greece)
- Province / Facility
- Ho Chi Minh City · 79037
|
520114446123 |
200mg
Injection
|
Vial |
60
|
735,500
|
44,130,000
|
N1 |
Manufacturing and primary packaging site: Vianex S.A.- Plant C (Secondary packaging and batch release site: Lilly France)
Greece
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Gemzar
Gemcitabin
- Strength / route
- 1000mg · Injection
- Qty
- 60 Vial
- Total
- 163,584,000
- Group
- N1
- Manufacturer
- Manufacturing and primary packaging site: Vianex S.A.- Plant C (Secondary packaging and batch release site: Lilly France) (Greece)
- Province / Facility
- Ho Chi Minh City · 79037
|
520114195923 |
1000mg
Injection
|
Vial |
60
|
2,726,400
|
163,584,000
|
N1 |
Manufacturing and primary packaging site: Vianex S.A.- Plant C (Secondary packaging and batch release site: Lilly France)
Greece
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Gimtafort
Hydrocortison
- Strength / route
- 10mg · Oral
- Qty
- 30,000 Tablet
- Total
- 133,500,000
- Group
- N4
- Manufacturer
- Enlie Pharmaceutical JSC (Vietnam)
- Province / Facility
- Bac Ninh · 27009
|
893110243724 |
10mg
Oral
|
Tablet |
30,000
|
4,450
|
133,500,000
|
N4 |
Enlie Pharmaceutical JSC
Vietnam
|
Bac Ninh
27009
|
2026-03-06 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 40mg · Oral
- Qty
- 480 Tablet
- Total
- 370,893,600
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN2-603-17 |
40mg
Oral
|
Tablet |
480
|
772,695
|
370,893,600
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 30mg · Oral
- Qty
- 480 Tablet
- Total
- 370,893,600
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN2-602-17 |
30mg
Oral
|
Tablet |
480
|
772,695
|
370,893,600
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Giotrif
Afatinib dimaleate
- Strength / route
- 20mg · Oral
- Qty
- 240 Tablet
- Total
- 185,446,800
- Group
- N1
- Manufacturer
- Boehringer Ingelheim Pharma GmbH & Co. KG (Germany)
- Province / Facility
- Ho Chi Minh City · 79037
|
400110034923 |
20mg
Oral
|
Tablet |
240
|
772,695
|
185,446,800
|
N1 |
Boehringer Ingelheim Pharma GmbH & Co. KG
Germany
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Glizym-M
Gliclazid + metformin
- Strength / route
- 80mg + 500mg · Oral
- Qty
- 30,000 Tablet
- Total
- 99,000,000
- Group
- N5
- Manufacturer
- M/s Panacea Biotec Pharma Ltd. (India)
- Province / Facility
- Quang Binh · 44001
|
VN3-343-21 |
80mg + 500mg
Oral
|
Tablet |
30,000
|
3,300
|
99,000,000
|
N5 |
M/s Panacea Biotec Pharma Ltd.
India
|
Quang Binh
44001
|
2026-03-06 |
|
Glucophage 500mg
Metformin
- Strength / route
- 500mg · Oral
- Qty
- 48,000 Tablet
- Total
- 76,704,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-21993-19 |
500mg
Oral
|
Tablet |
48,000
|
1,598
|
76,704,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Glucophage 850mg
Metformin
- Strength / route
- 850mg · Oral
- Qty
- 84,000 Tablet
- Total
- 289,128,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79037
|
VN-21908-19 |
850mg
Oral
|
Tablet |
84,000
|
3,442
|
289,128,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Glucophage XR 1000mg
Metformin
- Strength / route
- 1000mg · Oral
- Qty
- 18,000 Tablet
- Total
- 87,174,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79037
|
300110016324 |
1000mg
Oral
|
Tablet |
18,000
|
4,843
|
87,174,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79037
|
2026-03-06 |
|
Glucophage XR 1000mg
Metformin
- Strength / route
- 1000mg · Oral
- Qty
- 160,000 Tablet
- Total
- 774,880,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79021
|
300110016324 |
1000mg
Oral
|
Tablet |
160,000
|
4,843
|
774,880,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79021
|
2026-03-06 |
|
Glucophage XR 1000mg
Metformin
- Strength / route
- 1000mg · Oral
- Qty
- 25,000 Tablet
- Total
- 121,075,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79053
|
300110016324 |
1000mg
Oral
|
Tablet |
25,000
|
4,843
|
121,075,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79053
|
2026-03-06 |
|
Glucophage XR 750mg
Metformin
- Strength / route
- 750mg · Oral
- Qty
- 360,000 Tablet
- Total
- 1,323,720,000
- Group
- N1
- Manufacturer
- Merck Sante s.a.s (France)
- Province / Facility
- Ho Chi Minh City · 79037
|
300110016424 |
750mg
Oral
|
Tablet |
360,000
|
3,677
|
1,323,720,000
|
N1 |
Merck Sante s.a.s
France
|
Ho Chi Minh City
79037
|
2026-03-06 |
